Thomas McLean to Adult
This is a "connection" page, showing publications Thomas McLean has written about Adult.
Connection Strength
0.066
-
Sisk BA, Eng W, Aye J, Mack J, Tran A, Ogino J, Pearson E, Bies J, Smink G, Shah SD, Mohney L, Fassel H, Schulte R, Chang VY, Tessem RA, Hogeling M, Swaminathan N, McLean TW, Blatt J, Alturky S, Wu M, Atkinson A, Al-Huniti A, Massey G, Engel E, Ricci K, Echols T, Kumar S, Fox M, King KA. Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States. Pediatr Blood Cancer. 2025 Jun; 72(6):e31661.
Score: 0.023
-
McLean TW, Iskandar SS, Shimada H, Hall MC. Neuroblastoma in an adult. Urology. 2004 Dec; 64(6):1232.
Score: 0.023
-
McLean TW, Hertel C, Young ML, Marcus K, Schizer MA, Gebhardt M, Weinstein HJ, Perez-Atayde A, Grier HE. Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience. J Pediatr Hematol Oncol. 1999 Nov-Dec; 21(6):486-93.
Score: 0.016
-
Hall PD, Razzouk BI, Willoughby TE, McLean TW, Frankel AE. The majority of children and adolescents with acute myeloid leukemia have detectable anti-DT388-GMCSF IgG concentrations, but at concentrations that should not preclude in vivo activity. J Pediatr Hematol Oncol. 2002 Oct; 24(7):521-6.
Score: 0.005